Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Sales

Burning Rock Biotech (BNR) Net Margin: 2020-2024

Historic Net Margin for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to 67.20%.

  • Burning Rock Biotech's Net Margin rose 1957.00% to 13.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.80%, marking a year-over-year increase of 6396.00%. This contributed to the annual value of 67.20% for FY2024, which is 5443.00% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Net Margin of 67.20% as of FY2024, which was up 44.75% from 121.63% recorded in FY2023.
  • Burning Rock Biotech's Net Margin's 5-year high stood at 67.20% during FY2024, with a 5-year trough of 172.44% in FY2022.
  • For the 3-year period, Burning Rock Biotech's Net Margin averaged around 120.42%, with its median value being 121.63% (2023).
  • Per our database at Business Quant, Burning Rock Biotech's Net Margin tumbled by 2,878bps in 2021 and then soared by 5,443bps in 2024.
  • Over the past 5 years, Burning Rock Biotech's Net Margin (MRY) stood at 135.87% in 2020, then fell by 21bps to 164.65% in 2021, then decreased by 5bps to 172.44% in 2022, then rose by 29bps to 121.63% in 2023, then soared by 45bps to 67.20% in 2024.
  • Its Net Margin was 67.20% in FY2024, compared to 121.63% in FY2023 and 172.44% in FY2022.